Celanese Corporation — Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2022. Although the request references 2022 Q4, this filing reports full-year results; the supplied text does not provide a clear standalone fourth-quarter financial summary.
Business context
Celanese is a global chemicals and specialty materials company operating through Engineered Materials and Acetyl Chain. Its products serve markets including automotive, medical, construction, consumer, industrial and packaging. Effective December 31, 2022, the company reorganized its segments, moving Acetate Tow into Acetyl Chain; historical segment data was recast.
Financial results and liquidity
| Metric ($ millions, except per-share data and percentages) | 2022 | 2021 |
|---|---|---|
| Net sales | 9,673 | 8,537 |
| Gross profit | 2,380 | 2,682 |
| Operating profit | 1,378 | 1,946 |
| Operating margin | 14.2% | 22.8% |
| Net earnings attributable to Celanese | 1,894 | 1,890 |
| Diluted earnings per share | $17.34 | $16.86 |
| Cash from operations | 1,819 | 1,757 |
| Capital expenditures | 543 | 467 |
| Cash and cash equivalents at year-end | 1,508 | 536 |
| Total debt at year-end | 14,679 | 3,967 |
Revenue rose 13%, reflecting higher pricing and Engineered Materials acquisition-related volume, partly offset by weaker Acetyl Chain volume and unfavorable currency effects. Operating profit fell 29% as higher raw-material, energy, logistics, maintenance and acquisition-related costs outweighed sales growth. Interest expense increased to $405 million from $91 million.
Net earnings were supported by a $489 million income-tax benefit, primarily from an approximately $800 million deferred tax benefit associated with reorganizing foreign holding entities and relocating certain intangible assets. The reported effective tax rate was negative 34%, versus 15% in 2021.
Operating cash flow was approximately $1.8 billion. Investing activities used $11.1 billion, including the M&M acquisition; financing activities provided $10.3 billion, principally from new debt. The company had $1.45 billion available under its revolving credit facility, in addition to cash. It reported compliance with debt covenants at year-end. Approximately $1.3 billion of cash was held by foreign subsidiaries and was described as largely accessible without additional material tax consequences.
Segments and material changes
- Engineered Materials: Sales increased 48% to $4.024 billion, principally from the M&M and Santoprene acquisitions, the KEPCO restructuring and higher pricing. Operating profit rose 4% to $429 million, but margin declined to 10.7% from 15.1% as costs and spending increased.
- Acetyl Chain: Sales declined 3% to $5.743 billion, reflecting lower volume, especially in Asia, and currency effects, partly offset by higher pricing. Operating profit fell 23% to $1.447 billion; margin decreased to 25.2% from 31.8%.
- M&M acquisition: Celanese completed the acquisition on November 1, 2022, for a purchase price of $11.0 billion, subject to adjustments. The acquired business contributed $430 million of sales and a $80 million pretax loss after closing. Management said its performance from signing through closing was below prior expectations. Purchase accounting remained preliminary; goodwill recorded was $5.788 billion.
- Leverage: Debt rose substantially to finance the acquisition. The company issued $7.5 billion of U.S.-dollar notes and €1.5 billion of euro notes in 2022, and drew term loans. Scheduled principal payments include $1.306 billion in 2023 and $2.544 billion in 2024.
Outlook, risks and unusual items
- Management expected 2023 capital expenditures of approximately $600 million, focused on growth and productivity projects. The filing does not provide specific full-year earnings or revenue guidance.
- Management expected sourcing costs and inflationary pressures to improve in 2023, while noting that raw-material, energy and logistics pressures, customer destocking and weaker demand in parts of China and the Western Hemisphere created uncertainty. Acetyls pricing had moderated toward more normalized levels by year-end 2022.
- Key risks include acquisition integration and realization of synergies, elevated debt and interest costs, cyclical end-market demand, raw-material and energy price volatility, supply interruptions, foreign exchange movements, environmental and climate regulation, litigation and tax audits. The company suspended sales into Russia, Belarus and sanctioned regions of Ukraine; those areas represented less than 1% of sales in 2022 and 2021.
- Environmental remediation liabilities were $67 million at year-end. A proposed collective $150 million settlement for the Lower Passaic River cleanup remained subject to public comment and court approval; Celanese’s proposed share was described as not material. A methanol pipeline leak in Texas was contained and remediation completed; the company recorded a reserve and did not expect a material financial impact.
- The company expected environmental-control capital expenditures of $20 million to $40 million in each of 2023 and 2024. Its internal-control assessment excluded the acquired M&M business, representing 15% of consolidated assets and 4% of sales at year-end; the auditor likewise excluded it from its control audit.
Important facts for investors to verify
- Progress integrating M&M, its operating performance, final purchase-price allocation and the timing and achievability of projected synergies.
- Debt repayment capacity, refinancing needs, interest expense, covenant terms and liquidity available after scheduled maturities.
- Whether 2023 cost, pricing and demand trends support segment margins, particularly given lower 2022 operating margins.
- The sustainability of reported earnings given the substantial one-time tax benefit and the company’s future effective tax rate.
- Developments in tax examinations, environmental matters and other contingencies, including the Passaic River settlement approval.